Abstract
Background: COVID-19 might predispose individuals to elevated blood glucose levels as an effect of anxiety. Blood glucose level is an important risk factor for the prognosis of disease among diabetes patients. Purpose: This study aimed to assess the effect of Coronavirus-related anxiety with hyperglycemia incidence among type 2 diabetes patients. Methods: A cross-sectional study was conducted among 143 individuals with type 2 diabetes mellitus, from 25 January to 29 February 2021. This study was conducted both online and by assessing archives of medical records using random samples. Results: A total of 143 respondents completed the questionnaire, with 59.44% females and 40.56% males. More than half of the respondents (55.94%) who reported hyperglycemia showed COVID-19 anxiety, and 51.05% of them experienced ≥ 8 years of diabetes. COVID-19 anxiety was associated positively with the risk of hyperglycemia among type 2 diabetes patients (PR>1). Severe worry about the pandemic had the highest risk of hyperglycemia compared to moderate and mild anxiety. This finding is confounded by diabetes duration (PR discrepancy >10% and PR>1 for ≥8 years long-duration). Conclusion: This study suggests a positive association between COVID-19 anxiety and hyperglycemia while the degree of anxiety is associated with an increased risk of hyperglycemia.
Original language | English |
---|---|
Pages (from-to) | 111-120 |
Journal | Jurnal Berkala Epidemiologi |
Volume | 10 |
Issue number | 2 |
DOIs | |
Publication status | Published - Jun 2022 |
Keywords
- Coronavirus
- anxiety
- hyperglycemia
- type 2 diabetes